After the publication of the Laparoscopic Approach to Cervical Cancer (LACC) trial, open surgery has become the standard approach for radical hysterectomy in early stage cervical cancer. Recent studies assessed the role of a non-radical approach in low risk cervical cancer and showed no survival difference compared with radical hysterectomy. However, there is a gap in knowledge regarding the oncologic outcomes of minimally invasive simple hysterectomy in low risk cervical cancer. This review offers an overview of the current evidence on the role of the minimally invasive approach in low risk cervical cancer and raises the need for a new clinical trial in this setting.

Clinica Universidad de Navarra Departamento de Ginecologia y Obstetricia Pamplona Spain

Department of Obstetrics and Gynecology Centre Hospitalier Universitaire de Quebec Quebec Quebec Canada

Department of Obstetrics and Gynecology Houston Methodist Hospital Houston Texas USA

Department of Obstetrics and Gynecology University of Prague Prague Czech Republic

Department of Surgery Memorial Sloan Kettering Cancer Center New York New York USA

Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden

Università Cattolica del Sacro Cuore Rome Italy

UOC Ginecologia Oncologica Dipartimento di Scienze della Salute della Donna del Bambino e di Sanità Pubblica Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy

Zobrazit více v PubMed

Ramirez PT, Frumovitz M, Pareja R, et al. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med. 2018;379(20):1895–1904. doi:10.1056/NEJMoa1806395 PubMed DOI

Ramirez PT, Robledo KP, Frumovitz M, et al. LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. J Clin Oncol. Published online May 29, 2024. doi:10.1200/JCO.23.02335 PubMed DOI

Koh WJ, Abu-Rustum NR, Bean S, et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(1):64–84. doi:10.6004/jnccn.2019.0001 PubMed DOI

Querleu D, Cibula D, Concin N, et al. Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statement. Int J Gynecol Cancer. 2020;30(1):15. doi:10.1136/ijgc-2019-000775 PubMed DOI

Chiva L, Zanagnolo V, Querleu D, et al. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer. Int J Gynecol Cancer. 2020;30(9):1269–1277. doi:10.1136/ijgc-2020-001506. PubMed DOI

Kohler C, Hertel H, Herrmann J, et al. Laparoscopic radical hysterectomy with transvaginal closure of vaginal cuff - a multicenter analysis. Int J Gynecol Cancer. 2019;29(5):845–850. PubMed

Bizzarri N, Pedone Anchora L, Kucukmetin A, et al. Protective role of conization before radical hysterectomy in early-stage cervical cancer: a propensity- score matching study. Ann Surg Oncol. 2021;28(7):3585–94. 10.1245/s10434-021-09695-4. PubMed DOI

Chacon E, Manzour N, Zanagnolo V, et al. SUCCOR cone study: conization before radical hysterectomy. Int J Gynecol Cancer. 2022;32(2):117–124. doi:10.1136/ijgc-2021-002544 PubMed DOI

Nasioudis D, Labban N, Gysler S, et al. Outcomes of Radical Hysterectomy for Early-Stage Cervical Carcinoma, with or without Prior Cervical Excision Procedure. Cancers (Basel). 2024;16(11):2051. Published 2024 May 29. doi:10.3390/cancers16112051 PubMed DOI PMC

Plante M, Kwon JS, Ferguson S, et al. Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer. N Engl J Med. 2024;390(9):819–829. PubMed

Mahner S, Trillsch F, Kwon J, et al. 738 Surgical approach, preoperative LEEP/cone biopsy and patterns of recurrence and death in low-risk cervical cancer – analysis of the international CCTG CX.5/SHAPE phase III trial International Journal of Gynecologic Cancer 2024;34:A12.

Schmeler KM, Pareja R, Lopez Blanco A, et al. ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer. Int J Gynecol Cancer 2021;31:1317–25. PubMed PMC

Carneiro VCG, Batista TP, Andrade MR, et al. Proof-of-concept randomized phase II non-inferiority trial of simple versus type B2 hysterectomy in early-stage cervical cancer ≤2 cm (LESSER). Int J Gynecol Cancer. 2023;33(4):498–503. Published 2023 Apr 3. doi:10.1136/ijgc-2022-004092 PubMed DOI

Covens A, et al. “Evaluation of physical function and quality of life before and after non-radical surgical therapy (extra fascial hysterectomy or cone biopsy with pelvic lymphadenectomy) for stage IA1 (LVSI+) and IA2-IB1 cervical cancer (GOG-278)” SGO 2024.

Pedone Anchora L, Bizzarri N, Kucukmetin A, et al. Investigating the possible impact of peritoneal tumor exposure amongst women with early stage cervical cancer treated with minimally invasive approach. Eur J Surg Oncol. 2021;47(5):1090–1097. doi:10.1016/j.ejso.2020.09.038 PubMed DOI

Cibula D, Raspollini MR, Planchamp F, et al. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023. Int J Gynecol Cancer. 2023. May 1;33(5):649–666. doi: 10.1136/ijgc-2023-004429. PubMed DOI PMC

NCT Clinicaltrials.gov number for LASH trial: NCT06416748.